ArticleFrontiers in medicine2026
CMRA-DETR: a lightweight and high-accuracy detection framework for MRI-based brain tumor identification.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Brain tumor lesions in MRI images are characterized by low contrast, indistinct boundaries, and irregular morphology, posing substantial challenges for automated detection. RT-DETR provides an end-to-end, NMS-free detection paradigm, but its original design is optimized for natural images and exhibits three domain-specific limitations in brain tumor MRI detection: insufficient local texture perception of low-contrast lesion boundaries, neglect of feature magnitude differences in linear attention, and weak modeling of spatial continuity for morphologically irregular tumors. This study proposes CMRA-DETR (CSP-MambaOut with Retention and Magnitude-Aware Attention for Real-Time Detection Transformer), a lightweight yet high-accuracy detection framework built upon RT-DETR-R18, to address these limitations through targeted architectural adaptations. Methods: CMRA-DETR introduces three improvements: (1) a CSP-MambaOut backbone that enhances local texture perception of low-contrast lesion boundaries via gated feature selection; (2) an AIFI-MALA module that introduces magnitude-aware linear attention to correct the distributional smoothing deficiency of standard linear attention; and (3) a RetBlockC3 module that incorporates a Manhattan distance decay-based spatial retention mechanism to improve modeling of spatial continuity for morphologically irregular tumors. The model was trained and evaluated on an internal independent test set of 5,731 MRI images covering four categories (no tumor, meningioma, glioma, and pituitary adenoma), and further assessed on an external independent test set from the BRISC dataset without fine-tuning. Its performance was benchmarked against Faster R-CNN, YOLOv5n, YOLOv8n, YOLO11n, YOLO12n, and the RT-DETR-R18 baseline. Results and discussion: On the internal independent test set, CMRA-DETR achieved achieves
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.